H. Nacer-Laidi

Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study

A. Copas, A. Hayward, M. Shrotri, 2022, The Lancet Healthy Longevity.

Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study

A. Copas, A. Hayward, M. Shrotri, 2022, The Lancet Healthy Longevity.

Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of Long-Term Care Facilities (VIVALDI): a prospective cohort study, England, Dec 2020-Dec 2021

A. Copas, A. Hayward, M. Shrotri, 2022, medRxiv.

Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI)

A. Copas, A. Hayward, M. Shrotri, 2022, medRxiv.

SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)

A. Copas, R. Bruton, A. Hayward, 2022, medRxiv.

Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study

A. Copas, A. Hayward, M. Shrotri, 2022, The Lancet Healthy Longevity.